As a result, the translation of these biomarker candidates to real-life application in a clinical setting has lagged far behind. Quantitative, targeted proteomics approaches, however, are now ...

“As a scientific discipline, proteomics isn’t really that old – it’s like protein biochemistry gone crazy,” Dr. Jennifer Van Eyk, professor of cardiology, director of the Advanced Clinical Biosystems ...

This is only the beginning for clinical proteomics. The next iteration of the SomaScan platform — due for release in 2023 — will encompass 10,000 proteins, but still represents less than half ...

Meilahti Clinical Proteomics Core Facility is an optimised platform for clinical proteomics services. The broad expertise of our staff members both in clinical research and diseases provides the ...

Quantitative proteomics techniques were primarily developed with small sample numbers, but research involving clinical cohorts requires robust quantitation over a large number of samples. To ensure ...

Proteomics: Advances in Biomarker Discovery hosted by EuroSciCon. The speakers had a broad range of clinical and basic science interests, and presented data using a number of proteomic platforms ...

Morgans analyst Iain Wilkie maintained a Sell rating on Proteomics International Laboratories Ltd. (PIQ – Research Report) today and set a ...

NULISA employs a sequential immunocomplex capture and release technique to improve the sensitivity of traditional proximity ...

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in precision diagnostics is pleased to provide the following update on its busines ...

Add articles to your saved list and come back to them any time. Proteomics International’s share price surged as much as 24 per cent today on the best volume in more than two months to reach 75 ...